Search

Maria Ribadeneira Phones & Addresses

  • Chicago, IL
  • New York, NY
  • 52 Lee St, Cambridge, MA 02139
  • Morrisville, NC
  • 629 Montgomery Woods Dr, Hockessin, DE 19707 (302) 234-2430
  • Henderson, NV
  • Walker, LA
  • Decatur, GA
  • New Castle, DE

Resumes

Resumes

Maria Ribadeneira Photo 1

Executive Director Of Dmpk And Clinical Pharmacology

View page
Location:
629 Montgomery Woods Dr, Hockessin, DE 19707
Industry:
Pharmaceuticals
Work:
Forma Therapeutics, Inc.
Executive Director of Dmpk and Clinical Pharmacology

Ironwood Pharmaceuticals
Director Dmpk

Boehringer Ingelheim Sep 2010 - Mar 2013
Associate Director

Astrazeneca 2001 - 2010
Principal Scientist Ii
Education:
Georgia State University 1994
Doctorates, Doctor of Philosophy, Physiology, Philosophy
George Brown College
Skills:
Drug Discovery
Pharmaceutical Industry
Adme
Dmpk
Drug Development
Drug Metabolism
In Vitro
Pharmacology
Pharmacokinetics
Clinical Development
Assay Development
Biotechnology
Lc Ms
Bioanalysis
Biomarkers
In Vivo
Medicinal Chemistry
Hplc
Ind
High Throughput Screening
Drug Design
Glp
Cell Culture
Cro
Pharmaceutical Research
Pharmacodynamics
Lifesciences
Maria Ribadeneira Photo 2

Head Spanish Teacher

View page
Location:
90 West St, New York, NY 10006
Industry:
Education Management
Work:
Reade Street Prep
Head Spanish Teacher

Green Ivy Schools Jul 2015 - Jun 2016
Spanish Preschool Teacher

New York Kids Club Jul 2015 - Jun 2016
Spanish Teacher

The Green Beetle Mar 2010 - Jan 2011
Account Manager

Geoscape Sep 2007 - Feb 2010
Client Solutions Specialist
Education:
Universidad Católica Boliviana 1996 - 2000
Skills:
Marketing
Strategy
Marketing Research
Account Management
Social Media Marketing
Marketing Communications
Market Research
Advertising
Direct Marketing
Marketing Strategy
Online Advertising
Digital Marketing
Social Media
Competitive Analysis
Maria Ribadeneira Photo 3

Office Manager

View page
Location:
New York, NY
Industry:
Media Production
Work:
Cuatro Media
Office Manager
Education:
Universidad Católica Boliviana 1995 - 2000
Maria Ribadeneira Photo 4

Maria Ribadeneira

View page

Publications

Us Patents

Activating Pyruvate Kinase R

View page
US Patent:
20220304987, Sep 29, 2022
Filed:
Mar 18, 2022
Appl. No.:
17/698505
Inventors:
- Watertown MA, US
Neal Green - Newton MA, US
Gary Gustafson - Ridgefield CT, US
Gary Marshall - Watertown MA, US
Lorna Mitchell - Cambridge, NZ
David Richard - Littleton MA, US
Zhongguo Wang - Lexington MA, US
Sanjeev Forsyth - Milton MA, US
Patrick F. Kelly - Concord MA, US
Madhu Mondal - Winchester MA, US
Maria Ribadeneira - Cambridge MA, US
Patricia Schroeder - Somerville MA, US
International Classification:
A61K 31/436
A61P 9/00
Abstract:
The compound (S)-1-(5-((2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-7-yl)sulfonyl)-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-3-hydroxy-2-phenylpropan-1-one, or a pharmaceutically acceptable salt thereof, is useful to increase the affinity of hemoglobin for oxygen. Methods and compositions for the treatment of a hemoglobinopathies are provided herein, including certain pharmaceutical compositions for activating PKR.

Treating Sickle Cell Disease With A Pyruvate Kinase R Activating Compound

View page
US Patent:
20200405699, Dec 31, 2020
Filed:
Sep 1, 2020
Appl. No.:
17/008787
Inventors:
- Watertown MA, US
Neal GREEN - Newton MA, US
Gary GUSTAFSON - Ridgefield CT, US
Gary MARSHALL - Watertown MA, US
Lorna MITCHELL - West Beach, AU
David RICHARD - Littleton MA, US
Zhongguo WANG - Lexington MA, US
Sanjeev FORSYTH - Milton MA, US
Patrick F. KELLY - Concord MA, US
Madhu MONDAL - Winchester MA, US
Maria RIBADENEIRA - Cambridge MA, US
Patricia SCHROEDER - Somerville MA, US
International Classification:
A61K 31/436
A61P 7/06
A61K 9/00
Abstract:
Compounds that activate pyruvate kinase R can be used for the treatment of sickle cell disease (SCD). Methods and compositions for the treatment of SCD are provided herein, including a therapeutic compound designated as Compound 1.

Treatment Of Cns Diseases With Sgc Stimulators

View page
US Patent:
20190343813, Nov 14, 2019
Filed:
Nov 7, 2017
Appl. No.:
16/348359
Inventors:
- Cambridge MA, US
Thomas Wai-Ho Lee - Lexington MA, US
Rajesh R. Iyengar - West Newton MA, US
Nicholas Robert Perl - Somerville MA, US
Peter Germano - Newton MA, US
Maria D. Ribadeneira - Cambridge MA, US
Kim Tang - Belmont MA, US
Assignee:
Cyclerion Therapeutics, Inc. - Cambridge MA
International Classification:
A61K 31/437
A61K 31/519
A61K 31/5025
A61K 31/506
A61P 25/28
Abstract:
The present disclosure relates to the use of stimulators of soluble guanylate cyclase (sGC), pharmaceutically acceptable salts thereof and pharmaceutical formulations or dosage forms comprising them, alone or in combination with one or more additional agents, for the treatment of various CNS diseases, wherein an increase in sGC stimulation, or an increase in the concentration of nitric oxide (NO), or cyclic guanosine 3′,5′-monophosphate (cGMP) or both, or an upregulation of the NO pathway is desirable.
Maria D Ribadeneira from Chicago, IL, age ~68 Get Report